Literature DB >> 1112301

The effect of L-dopa, noradrenalin and adrenalin on P-388 mouse leukemia, B-16 mouse melanoma and E 0771 mammary carcinoma.

B Shohat, E Kott, B Bornstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1112301     DOI: 10.1007/bf01924707

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  Antitumour activity of dopa, dopamine, noradrenalin or adrenalin and their reaction with nucleic acids.

Authors:  K Yamafuji; H Murakami; M Shinozuka
Journal:  Z Krebsforsch       Date:  1970

2.  Levodopa and melanoma.

Authors:  A N Lieberman; J L Shupack
Journal:  Neurology       Date:  1974-04       Impact factor: 9.910

3.  Levodopa and malignant melanoma.

Authors:  E Robinson; J Wajsbort; B Hirshowitz
Journal:  Arch Pathol       Date:  1973-03

4.  Effect of L-DOPA on transplanted malignant melanomas in mice.

Authors:  E Robinson; J Wajsbort; T Mekori
Journal:  Isr J Med Sci       Date:  1973-08

5.  Multiple primary melanoma following administration of levodopa.

Authors:  J L Skibba; J Pinckley; E F Gilbert; R O Johnson
Journal:  Arch Pathol       Date:  1972-06

6.  Stimulation of human-growth-hormone secretion by L-dopa.

Authors:  A E Boyd; H E Lebovitz; J B Pfeiffer
Journal:  N Engl J Med       Date:  1970-12-24       Impact factor: 91.245

7.  Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines.

Authors:  R M MacLeod; E H Fontham; J E Lehmeyer
Journal:  Neuroendocrinology       Date:  1970       Impact factor: 4.914

8.  THE INCORPORATION OF C14 FROM 3,4-DIHYDROXYPHENYLALANINE-2'-C14 INTO THE MELANIN OF MOUSE MELANOMAS.

Authors:  M S BLOIS; R F KALLMAN
Journal:  Cancer Res       Date:  1964-06       Impact factor: 12.701

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.